Simultaneous development of Graves' disease and type 1 diabetes during anti-programmed cell death-1 therapy: A case report

Kurihara, S; Oikawa, Y; Nakajima, R; Satomura, A; Tanaka, R; Kagamu, H; Shimada, A

Oikawa, Y (corresponding author), Saitama Med Univ, Sch Med, Dept Endocrinol & Diabet, Saitama, Japan.

JOURNAL OF DIABETES INVESTIGATION, 2020; 11 (4): 1006

Abstract

We present the first case of simultaneous development of Graves' disease and type 1 diabetes during anti-programmed cell death 1 therapy. A 48-year-ol......

Full Text Link